Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study
Oncology · 2024
DOI: 10.1159/000542369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Zhi Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tian…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Adenocarcinoma. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Introduction
The clinicopathological characteristics and efficacy of perioperative treatment of Epstein-Barr virus-associated gastric cancer (EBVaGC) were investigated.
Methods
The clinicopathological characteristics and perioperative treatment outcomes of patients with EBVaGC who underwent radical gastrectomy in Tianjin Medical University Cancer Hospital from September 2016 to May 2022 were retrospectively reviewed. Disease-free survival (DFS) was analyzed, and Cox regression analysis was performed to identify risk factors.
Results
The study cohort included 128 patients with EBVaGC. Histologically, 126 (98.4%) patients had adenocarcinoma and only 2 (1.6%) had adenosquamous carcinoma. In addition, 18 (14.1%) had nerve invasion and 29 (22.7%) had vascular invasion. Notably, 41 (32.0%) patients had tumors in the proximal stomach and 69 (53.9%) had no lymph node metastasis. Proficient mismatch repair was confirmed in all 104 patients with available results. Overall, 16 (12.5%) patients received neoadjuvant therapy, 81 (63.3%) received adjuvant therapy, and 10 (7.8%) received perioperative immunotherapy combined with chemotherapy. In total, 22 patients experienced disease progression or had died. The 3-year DFS rate was 75.0%. DFS was relatively poorer for patients with advanced tumor (T) stage, lymph node (N) stage, disease stage, and vascular invasion.
Conclusion
EBVaGC had unique clinicopathological characteristics and prognosis. Advanced T, N, and disease stages, in addition to vascular invasion, were predictive of poorer DFS. However, the efficacy of perioperative treatment of EBVaGC remains uncertain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Pr…
Zitieren
APA
Ji, Z., Zhu, L., Wang, X., Li, H., Duan, J., Zhang, L., Deng, T., Liu, R., & Ba, Y. (2024). Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study. Oncology. https://doi.org/10.1159/000542369
Vancouver
Ji Z, Zhu L, Wang X, Li H, Duan J, Zhang L, et al. Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study. Oncology. 2024. doi:10.1159/000542369
BibTeX
@article{Ji2024,
author = {Ji, Zhi and Zhu, Lila and Wang, Xia and Li, Hongli and Duan, Jingjing and Zhang, Le and Deng, Ting and Liu, Rui and Ba, Yi},
title = {Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study},
journal = {Oncology},
year = {2024},
doi = {10.1159/000542369}
}
EUVIMED